Abstracts tagged "Hepatitis and rituximab"

Abstract Number: 2806 • ACR/ARHP Annual Meeting 2013
Low Risk Of Hepatitis B Virus Surface Antigen Seroreversion In HBsAg Negative/Anti-Hbc Positive Carriers Undergoing Rituximab For Rheumatoid Arthritis
Valentina Varisco¹, Mauro Vigano'², Alberto Batticciotto¹, Pietro Lampertico³, Antonio Marchesoni⁴, Patrizia Gibertini⁴, Raffaele Pellerito⁵, Guido Rovera⁶, Roberto Caporali⁷, Monica Todoerti⁷, Michele Covelli⁸, Antonella Notarnicola⁸ and Piercarlo Sarzi-Puttini⁹, ¹Rheumatology, Rheumatology Unit, L. Sacco University Hospital, Milan, Italy, ²Hepatology, San Giuseppe hospital, University of Milan,, Milan, Italy, ³Gastroenterology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, University of Milan,, Milan, Italy, ⁴Rheumatology, Istituto Ortopedico Gaetano Pini, Milano, Italy, ⁵Medicina II, Ospedale Mauriziano, Turin, Italy, ⁶Rheumatology, Ospedale Mauriziano, Turin, Italy, ⁷Rheumatology, Rheumatology, IRCCS Policlinico San Matteo Foundation and University of Pavia, Pavia, Italy, ⁸D.I.M.I.M.P, Rheumatology Unit - University of Bari, Bari, Italy, ⁹Rheumatology Unit, L. Sacco University Hospital, Milan, Italy
Background/Purpose: B cell-targeted therapy using rituximab (RTX), anti-CD20 monoclonal antibody, is an effective treatment for Rheumatoid arthritis (RA). However, the safety of such therapy in…
Abstract Number: 1612 • ACR/ARHP Annual Meeting 2013
Rituximab For Treatment Of Refractory Auto-Immune Hepatitis
Chadi Rakieh¹, Edward M. Vital², Paul Emery³ and Michael Martin¹, ¹Rheumatology, Division of Rheumatic and Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, LTHT, Leeds, United Kingdom, Leeds, United Kingdom, ²Section of Musculoskeletal Disease, Division of Rheumatic and Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, LTHT, Leeds, United Kingdom, Leeds, United Kingdom, ³Division of Rheumatic and Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, LTHT, Leeds, United Kingdom, Leeds, United Kingdom
Background/Purpose: Auto-immune hepatitis (AIH), also known as lupoid hepatitis, is a chronic progressive disease of unknown aetiology. First-line therapy consists of corticosteroids alone or in…